Login / Signup

Higher thresholds for the utilization of steatotic allografts in liver transplantation: Analysis from a U.S. national database.

Justin A SteggerdaMatthew B BloomMazen NoureddinTodd V BrennanTsuyoshi TodoNicholas N NissenAndrew S KleinIrene K Kim
Published in: PloS one (2020)
In conjunction with recipient selection, organs with MaS up to 50% may be safely used without detriment to outcomes.
Keyphrases
  • quality improvement
  • type diabetes
  • metabolic syndrome
  • adipose tissue
  • skeletal muscle
  • insulin resistance
  • electronic health record